These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 6360159

  • 1. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG, Owen JS, Bruckdorfer KR.
    Biochem J; 1983 Oct 15; 216(1):43-9. PubMed ID: 6360159
    [Abstract] [Full Text] [Related]

  • 2. The effect of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets.
    Bruckdorfer KR, Buckley S, Hassall DG.
    Biochem J; 1984 Oct 01; 223(1):189-96. PubMed ID: 6093767
    [Abstract] [Full Text] [Related]

  • 3. Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase.
    Colli S, Maderna P, Tremoli E, Baraldi A, Rovati GE, Gianfranceschi G, Nicosia S.
    Biochem Pharmacol; 1985 Jul 15; 34(14):2451-7. PubMed ID: 3893439
    [Abstract] [Full Text] [Related]

  • 4. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function.
    Nordøy A, Svensson B, Wiebe D, Hoak JC.
    Circ Res; 1978 Oct 15; 43(4):527-34. PubMed ID: 210972
    [Abstract] [Full Text] [Related]

  • 5. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins.
    Saniabadi AR, Umemura K, Shimoyama M, Adachi M, Nakano M, Nakashima M.
    Thromb Haemost; 1997 May 15; 77(5):996-1001. PubMed ID: 9184417
    [Abstract] [Full Text] [Related]

  • 6. Aggregation of gel-filtered guinea-pig platelets by lipoproteins.
    Fujitani B, Tsuboi T, Yoshida K, Shimizu M.
    Thromb Haemost; 1979 Apr 23; 41(2):416-24. PubMed ID: 224521
    [Abstract] [Full Text] [Related]

  • 7. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
    Vlasova II, Vakhrusheva TV, Azizova OA, Lopukhin IuM.
    Vopr Med Khim; 1998 Apr 23; 44(1):43-54. PubMed ID: 9575612
    [Abstract] [Full Text] [Related]

  • 8. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM, Forscher CA, Sussman II, Mueller HS.
    Am Heart J; 1985 Jun 23; 109(6):1258-63. PubMed ID: 2988323
    [Abstract] [Full Text] [Related]

  • 9. Influence of plasma lipoproteins on platelet aggregation in a normal male population.
    Hassall DG, Forrest LA, Bruckdorfer KR, Marenah CB, Turner P, Cortese C, Miller NE, Lewis B.
    Arteriosclerosis; 1983 Jun 23; 3(4):332-8. PubMed ID: 6882287
    [Abstract] [Full Text] [Related]

  • 10. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA, Kappa JR, Sinha AK, Cottrell ED, Reiser HJ, Addonizio VP.
    J Lab Clin Med; 1987 Feb 23; 109(2):184-90. PubMed ID: 2433373
    [Abstract] [Full Text] [Related]

  • 11. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.
    Rao GH, Reddy KR, White JG.
    Prostaglandins Med; 1980 Jun 23; 4(6):385-97. PubMed ID: 6251492
    [Abstract] [Full Text] [Related]

  • 12. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR, Belch JJ, Lowe GD, Barbenel JC, Forbes CD.
    Haemostasis; 1987 Jun 23; 17(3):147-53. PubMed ID: 2440771
    [Abstract] [Full Text] [Related]

  • 13. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR, Lowe GD, Belch JJ, Barbenel JC, Forbes CD.
    Haemostasis; 1984 Jun 23; 14(6):487-94. PubMed ID: 6442909
    [Abstract] [Full Text] [Related]

  • 14. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.
    Rand ML, Gross PL, Jakowec DM, Packham MA, Mustard JF.
    Thromb Haemost; 1989 Apr 25; 61(2):254-8. PubMed ID: 2546284
    [Abstract] [Full Text] [Related]

  • 15. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB, Miller OV, Spillers C, Gorman RR.
    Prostaglandins; 1983 Aug 25; 26(2):287-302. PubMed ID: 6316420
    [Abstract] [Full Text] [Related]

  • 16. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K, Löbel P, Steinhagen-Thiessen E.
    Eicosanoids; 1989 Aug 25; 2(1):39-45. PubMed ID: 2483819
    [Abstract] [Full Text] [Related]

  • 17. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J, Parkinson S, Timmons S.
    Nature; 1980 Jan 10; 283(5743):195-7. PubMed ID: 6985716
    [Abstract] [Full Text] [Related]

  • 18. Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding.
    Volf I, Roth A, Moeslinger T, Cooper J, Schmid W, Zehetgruber M, Koller E.
    Thromb Res; 2000 Mar 15; 97(6):441-9. PubMed ID: 10704653
    [Abstract] [Full Text] [Related]

  • 19. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A, Stierle A, Anton R, Cazenave JP.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3597-600. PubMed ID: 6295405
    [Abstract] [Full Text] [Related]

  • 20. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
    Ehrman ML, Jaffe EA.
    Prostaglandins; 1980 Dec 15; 20(6):1103-16. PubMed ID: 7010448
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.